BERGER, Thomas
BERGER, Thomas
Dipartimento di Scienze Chimiche e Farmaceutiche (attivo dal 01/01/2012 al 31/12/2022)
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.003 secondi).
Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists
2025 Berger, Thomas; Zeitlinger, Markus; Popescu, Veronica; Magyari, Melinda; Airas, Laura; Alkhawajah, Mona; Pugliatti, Maura; Zakaria, Magd; Pozzilli, Carlo; Drulovic, Jelena; Van Wijmeersch, Bart; Vermersch, Patrick; Oreja‐guevara, Celia
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations
file con accesso da definire2022 Pugliatti, Maura; Berger, Thomas; Hartung, Hans-Peter; Oreja-Guevara, Celia; Bar-Or, Amit
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists | 2025 | Berger, Thomas; Zeitlinger, Markus; Popescu, Veronica; Magyari, Melinda; Airas, Laura; Alkhawajah..., Mona; Pugliatti, Maura; Zakaria, Magd; Pozzilli, Carlo; Drulovic, Jelena; Van Wijmeersch, Bart; Vermersch, Patrick; Oreja‐guevara, Celia | |
| Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations | 2022 | Pugliatti, Maura; Berger, Thomas; Hartung, Hans-Peter; Oreja-Guevara, Celia; Bar-Or, Amit | file con accesso da definire |